← FDA Drug Approvals (Drugs@FDA)

MYQORZO

NDA · New Drug Application · Sponsor: CYTOKINETICS · Approved 2025-12-19

Drug application

FDA Application #

NDA219083

Application type

New Drug Application

Brand name

MYQORZO

Generic name

AFICAMTEN

Active ingredients

AFICAMTEN

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

CYTOKINETICS

Manufacturer

Cytokinetics Inc.

First approval

2025-12-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown